Quite interesting article, one should explore all possibilities for the chronic disease called #obesity

Remarkable improvement in overnight #timeinrange with the #closed_loop arm in pregnancy. Every little helps: Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes | NEJM nejm.org/doi/full/10.10…

Incredible insights from Tim Street Diabettech on “the end of carb counting” using oref1 algorithm in AndroidAPS and Lyumjev #insulin Remarkable work shaping the future of mealtime management for people with #diabetes 🙌🏻 #ddata2023 #diabetescare #innovation DiabetesMine Innovation Project

Despite the limitations of the study, very useful data for #pregnancy and #T2DM Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy jamanetwork.com/journals/jamai…

Reassuring data for men with #hypogonadism on #TRT: Prostate Safety Events During Testosterone Replacement Therapy jamanetwork.com/journals/jaman…

It's been a huge privilege to have the EiC role at ETJ and it has been hard work but overall enjoyable. Over 4.5 years I have read around 1,200 submitted papers: what follows is 4 common & easy fixes for authors. 1/6

In #T2DM, #Metformin, #SGLT2i, #Pioglitazone, & #GLP1RA were associated with ⤵️ #Dementia risk, while #sulphonylureas & #meglitinides were associated with ⤴️ risk of demential. #insulin, #DDP4i, & #alpha_galacsidase_inhibitor were neutral. dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

In real world data, no higher risk for suicidal ideation was noted in people using #semaglutie as per this Nature article nature.com/articles/s4159…

In view of the amazing developments in the field of #obesity therapy, we are in great need for accurate phenotyping and biomarkers to guide which therapy fits best for which patient. #precision_medicine. Exciting times nature.com/articles/s4136…

Significant benefit of the #GLP1RA #Lixisenatide on #parkinsonsDisease progression in this Phase 2 trial. Is this a class effect? 🤔 Trial of Lixisenatide in Early Parkinson’s Disease | New England Journal of Medicine nejm.org/doi/full/10.10…

It looks there is something on the horizon to nail Lp (a). Impressive data for Zerlasiran. Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a) jamanetwork.com/journals/jama/…

Fascinating data. The worry of lactic acidosis does not seem to be there, and in these vulnerable patients cardiovascular protection is an amazing gain

Great presentation by David Preiss -LENS RCT Fenofibrate in people with early diabetic retinopathy Significant improvements in referrable retinopathy👏👏👏 #ADA2024 Orlando

GLP1 receptor gene variants can affect GLP1 agonists effects on MACE reduction #ADA2024 #ADASciSessions #obesity

Final paragraph of my new review Diabetes Care, an ADA research journal 🌟 open access #ADA2024 diabetesjournals.org/care/article/d…

A snapshot of changes in #diabetes therapies and outcomes over time from Denmark Diabetes Care, a research journal of the ADA 🌟 diabetesjournals.org/care/article-a…

Fascinating study about intake of mutivitamins, no mortality advantage, may be some harm in some people. Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts jamanetwork.com/journals/jaman…

Very impressive P2 data and #weightloss for a new biweekly GLO-1 medicine ca.finance.yahoo.com/news/gan-lee-p…

The often discussed as yet unpublished ELAD study hints at benefits of liraglutide after 1 year in 204 PPL with mild #AlzheimersDisease in preserving cognitive function and brain volume without effect on cerebral glucose metabolism aaic.alz.org/releases-2024/…

Semaglutide and Opioid Overdose Risk in Patients With T2D and OUD jamanetwork.com/journals/jaman…